- Home
- BPMC vs OMAB Comparison
BPMC vs OMAB Comparison
Compare BPMC & OMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPMC
- OMAB
- Stock Information
- Founded
- BPMC 2008
- OMAB 1998
- Country
- BPMC United States
- OMAB Mexico
- Employees
- BPMC N/A
- OMAB N/A
- Industry
- BPMC Biotechnology: Pharmaceutical Preparations
- OMAB Aerospace
- Sector
- BPMC Health Care
- OMAB Consumer Discretionary
- Exchange
- BPMC Nasdaq
- OMAB Nasdaq
- Market Cap
- BPMC 5.8B
- OMAB 4.8B
- IPO Year
- BPMC 2015
- OMAB 2006
- Fundamental
- Price
- BPMC $101.35
- OMAB $99.26
- Analyst Decision
- BPMC Buy
- OMAB Buy
- Analyst Count
- BPMC 18
- OMAB 4
- Target Price
- BPMC $125.88
- OMAB $102.50
- AVG Volume (30 Days)
- BPMC 789.4K
- OMAB 87.8K
- Earning Date
- BPMC 05-01-2025
- OMAB 07-25-2025
- Dividend Yield
- BPMC N/A
- OMAB 4.58%
- EPS Growth
- BPMC N/A
- OMAB 2.49
- EPS
- BPMC N/A
- OMAB 0.65
- Revenue
- BPMC $562,121,000.00
- OMAB $728,352,552.00
- Revenue This Year
- BPMC $44.49
- OMAB $6.46
- Revenue Next Year
- BPMC $33.04
- OMAB $12.84
- P/E Ratio
- BPMC N/A
- OMAB $19.01
- Revenue Growth
- BPMC 99.19
- OMAB N/A
- 52 Week Low
- BPMC $73.04
- OMAB $59.08
- 52 Week High
- BPMC $121.90
- OMAB $102.74
- Technical
- Relative Strength Index (RSI)
- BPMC 56.34
- OMAB 64.92
- Support Level
- BPMC $94.38
- OMAB $95.19
- Resistance Level
- BPMC $102.52
- OMAB $98.62
- Average True Range (ATR)
- BPMC 3.77
- OMAB 2.51
- MACD
- BPMC -0.38
- OMAB -0.70
- Stochastic Oscillator
- BPMC 79.29
- OMAB 64.16
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.
About OMAB Grupo Aeroportuario del Centro Norte S.A.B. de C.V. ADS
Grupo Aeroportuario del Centro Norte SAB de CV operates airports in the central region of Mexico. The airport is in Monterrey, which serves nearly half of the company's total passengers. In addition, the company manages two hotels and one industrial park. Its reportable segments include its airports, the Terminal 2 NH Collection Hotel, the Hilton Garden Inn Hotel and the OMA-VYNMSA Industrial Park, individually, and information about its holding company and other companies is combined in the Others.